SharesGrow.com Intrinsic Value of S&P & Nasdaq Contact Us

हिन्दी

← Back to all stocks

BioDelivery Sciences Intl, Inc. Wrrt BDSIW NASDAQ

NASDAQ • Healthcare • Drug Manufacturers - General • US • USD

SharesGrow Score

SharesGrow Intrinsic Value

Negative cash flow

BioDelivery Sciences Intl, Inc. Wrrt (BDSIW) is a Drug Manufacturers - General company in the Healthcare sector, currently trading at $0.04. It has a SharesGrow Score of 79/100, indicating a strong investment profile with 4 out of 7 criteria passed.

Financials: revenue is $167M, +48.5%/yr average growth. Net income is $85M, growing at +184.3%/yr. Net profit margin is 50.9% (strong). Gross margin is 86% (+14.4 pp trend).

Balance sheet: total debt is $59M against $188M equity (Debt-to-Equity (D/E) ratio 0.31, conservative). Current ratio is 2.45 (strong liquidity). Debt-to-assets is 18.1%. Total assets: $325M.

SharesGrow 7-Criteria breakdown: Value 100/100 (Pass), Growth 100/100 (Pass), Past 50/100 (Partial), Health 83/100 (Pass), Moat 58/100 (Partial), Future ?/100 (Fail), Income 100/100 (Pass).

BDSIW SharesGrow Score Overview

82/100

SharesGrow Score

Strong investment profile

View full scorecard →

VALUE 100/100

Valuation — P/E, PEG, Forward PEG

GROWTH 100/100

Financials — average growth

PAST 50/100

strong — trend

HEALTH 83/100

Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is

MOAT 58/100

Gross margin is + market cap

FUTURE 0/100

Analyst outlook — as buy

INCOME 100/100

Net profit margin is

Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — BDSIW

BDSIW trades at a trailing Price-to-Earnings (P/E) of N/A (S&P 500 average ~25). Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + upside (25%) + trailing PEG (20%). ≥ 60 = Pass.

View details →

BDSIW: +48.5%/yr revenue is, +184.3%/yr Net income is average growth. > 5%/yr — strong. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.

View details →

BDSIW: 2 / 4 years profitable. weak. Score = 2 / 4 × 100. ≥ 80 = Pass.

View details →

Balance sheet BDSIW: Debt-to-Equity (D/E) ratio 0.31 (conservative), Current ratio is 2.45 (strong liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.

View details →

BDSIW: Gross margin is 86% (+14.4 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 58/100. ≥ 70 = Pass.

View details →

No analyst coverage available for this stock.

BDSIW: Net profit margin is 50.9%. strong (≥30%). Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.

View details →

Stock Chart & Stats

Market Data

52-Week Range1.9199-0.03

Volume552.11K

Avg Volume (30D)27.73K

Beta (1Y)17.76

Share Statistics

EPS (TTM)0.82

Shares Outstanding$103.29M

IPO Date2002-06-25

Financial Highlights & Ratios

Revenue (TTM)$166.7M

Gross Profit$143.33M

EBITDA$44.54M

Net Income$84.86M

Operating Income$37.12M

Total Cash$114.31M

Total Debt$58.79M

Net Debt$-55.52M

Total Assets$324.6M

Price / Earnings (P/E)0

Analyst Forecast

Company Info

CountryUS

ExchangeNASDAQ

CurrencyUSD

ISINUS0742411046

Price Chart

BDSIW

BioDelivery Sciences Intl, Inc. Wrrt ↗ · NASDAQ

Healthcare • Drug Manufacturers - General

People Also View

Eli Lilly and Company

Johnson & Johnson

Roche Holding AG

Roche Holding AG

AstraZeneca PLC

Merck & Co., Inc.

Contact Us

🎓

SharesGrow Academy

Learn how to calculate Intrinsic Value and find undervalued stocks.

Weekly live sessions

📧 [email protected]

📞 +65 8912 8000

Send us a message